Short Interest in ReWalk Robotics Ltd. (NASDAQ:LFWD) Declines By 5.9%

ReWalk Robotics Ltd. (NASDAQ:LFWD) saw a large drop in short interest in October. As of October 15th, there was short interest totalling 188,100 shares, a drop of 5.9% from the September 30th total of 199,800 shares. Based on an average trading volume of 36,800 shares, the days-to-cover ratio is presently 5.1 days. Currently, 2.7% of the company’s stock are short sold.

Analyst Ratings Changes

Separately, HC Wainwright boosted their price objective on shares of ReWalk Robotics from $9.00 to $13.00 and gave the stock a “buy” rating in a research note on Friday, August 16th.

Institutional Investors Weigh In On ReWalk Robotics

An institutional investor recently bought a new position in ReWalk Robotics stock. Kent Lake Capital LLC acquired a new position in ReWalk Robotics Ltd. (NASDAQ:LFWD) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 157,361 shares of the company’s stock, valued at approximately $823,000. Kent Lake Capital LLC owned approximately 1.85% of ReWalk Robotics as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 26.76% of the company’s stock.

ReWalk Robotics Trading Down 4.8 %

Shares of NASDAQ:LFWD opened at $2.20 on Friday. The stock has a fifty day simple moving average of $3.00 and a two-hundred day simple moving average of $3.87. ReWalk Robotics has a 12-month low of $2.20 and a 12-month high of $9.10. The stock has a market capitalization of $18.93 million, a price-to-earnings ratio of -0.71 and a beta of 2.02.

ReWalk Robotics (NASDAQ:LFWD) last announced its quarterly earnings results on Thursday, August 15th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.53) by $0.03. The company had revenue of $6.71 million for the quarter, compared to analysts’ expectations of $6.71 million. ReWalk Robotics had a negative net margin of 102.03% and a negative return on equity of 41.89%. During the same quarter in the previous year, the business posted ($0.35) EPS. As a group, equities research analysts predict that ReWalk Robotics will post -1.65 EPS for the current year.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.